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DURING the 11 years 1955 to 1965 just under 6,000,000 people died in England
and Wales, 1,084,751 of them, 18-4 per cent, of malignant disease (Registrar
General, 1967). The total number of deaths from tumour in men was 579,527,
19 1 per cent ofthe total male deaths; while in women the total oftumour deaths
was 505,224, 17-6 per cent ofthe total deaths. This close approximation however
gives a false impression as tumour deaths occur predominantly among the older
members of the population and there are many more older women than men.
A better idea ofthe relative frequency ofneoplasms in men and women may be
obtained from a study of the different rates of tumour mortality throughout life.
In the six year period 1958 to 1963 the deaths of 234,508 women were attributed
to malignant disease, had the age-specific death rates for malignant tumours
experienced by men applied to women 379,175 deaths would have been expected.
It must be remembered, moreover, that the sex organs differ in the two sexes
both in anatomical form and physiological function and also in their liabilityto
neoplasia. Tumours of the ovary are far commoner than those of the testis,
uterine cancer is commoner, especially in younger women than is prostatic cancer
which tends to occur most often in much older men. The breast is a large active
organ in the female but a rudimentary vestige in the male. Lung cancer on the
other hand is very much commoner in males than in females and this difference
can reasonably be attributed in large part to the greater frequency of cigarette
smoking in men than in women (Kreyberg, 1962). For these reasons I thought it
useful to calculate the relative frequencies of tumours in the two sexes after
excluding neoplasms of the lung, the breast and the genital organs. In the same
six year period, 1958 to 1963, the number of deaths in this category in women
totalled 160,120 while, had the rates seen in men applied to women, the total
would have been expected to be 285,352, a female to male ratio of0-56. A similar
calculation was made on the data on the incidence of cancer in four regions of
England and Wales for the three vears 1962-64 given in " Cancer Incidence in
Five Continents " (Doll, Payne and Waterhouse, 1966). The total cases in women
were 42,933; had the male rates applied the total would have been 70,378, a female
to male ratio of 0-61.
An equivalent calculation is that which compares the age-adjusted incidence
and mortality rates. Dorn and Cutler (1955) gave such rates for the white and
non-white elements of the population in 10 Metropolitan areas of the United
States. The resident cancer incidence rate per 100,000 was 338-3 for white males
and 333-4 for white females, a female to male ratio of 0 99. It was 252-6 for non-
white males and 293-0 for non-white females, female to male ratio 1-16. After
deduction of the rates for cancer of the lung, breast and genital system the ratesD. J. B. ASHLEY
were: for white males 269-4, for white females 180.0, female to male ratio 0-67;
and for non-white males 173-0, for non-white females 124-9, female to male ratio
0-72.
Doll and his colleagues have given extensive data on tumour incidences in the
five continents (Doll et al., 1966). I have extracted from their tables the total
age adjusted cancer incidence rates and the rates for all tumours except those of
the lung, breast and genital organs. Table I shows the ratios between the male
TABLE I.-Female to Male Ratio Cancer Incidence
(from Cancer Incidence in Five Continents, Doll et al., 1966,
based on World Population Distribution)
Mozambique
Ibadan
Bantu (S. Africa)
Uganda
Canada (5 provinces)
Chile .
Colombia
Jamaica
Puerto Rico
Connecticut (U.S.A.)
New York State (U.S.A.)
Israel.
Japan
Singapore (Chinese)
Denmark
England and Wales (4 regions)
Finland
W. Germany (Hamburg)
Iceland
Holland
Norway
Sweden
Yugoslavia
New Zealand
Hawaii
Total tumours
0 66
1.15
1 33
1 35
0 93
1-11
1-12
1-06
0 93
0-82-
0-85
1 *02
0 79
0 70
1 05
0 76
0 70
0 89
0 97
0 89
0-98
1 04
0 87
0 84
1*01
Less lung,
breast, genital
0 45
0 65
0 72
0 83
0 66
0 66
0 66
0 62
0 66
0 65
0- 65
0 83
0 57
0 40
0 75
0 64
0 70
0 64
0 69
0 66
0 69
0-71
0 66
0 69
0 65
and female rates on the basis of the population distribution of the world. In 10
countries there is a greater total incidence among women than men and in the
remaining 15 a greater incidence among men than women. When tumours ofthe
lung, breast and genital organs are excluded there is a higher incidence in men
than in women in each of the 25 areas. Table II shows the result of a similar
calculation for the 12 areas in which the population is of Western European stock
and in which the rates are based on the European population distribution. In
Denmark only the gross rate for women was higher than that for men. In no case
was the ratio female to male for tumours, excluding those of the lung, breast and
genital organs, greater than 0 75. The weighted means of the female to male
ratios were calculated for the data in Table II using the populations ofthe several
registries as weights. The mean ratio for incidence of all tumours was 0-82; the
mean ratio for incidence from tumours other than those of the lung, breast and
genital organs was 0-66. There was a significant positive correlation between the
tumour rates in men and women but not between the sex ratio and either the rate
in men or that in women.
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TABLE II.-Female to Male Ratio Cancer Incidence
(from Cancer Incidence in Five Continents, Doll et al., 1966,
based on European Population Distribution)
Less lung,
Total tumours breast, genital
Canada . . . . 089 . 066
Connecticut . . . 079 063
New York . . . . 081 . 064
Denmark . . . . 102 075
England and Wales . . 073 0 63
Finland . . . . . 068 . 066
West Germany . . . . 085 . 061
Iceland . . . . . 093 . 067
Holland . . . . 085 0 65
Norway . . . . 094 . 069
Sweden . . . . 099 068
New Zealand . . . . 079 0 68
The existence of this sex difference is well known and is usually mentioned in
passing by those writing works of general oncology. Willis (1960) states that
there is a preponderance of males in most internal cancers and goes on to cite a
male excess in 29 different tumour types and a female excess in only 7. Warren
and Meissner (1966) state that the difference in incidence is often striking; they
suggest that it may be explained by habitat and environment but that it is
possible that sex hormones may be directly related. The overall difference is
apparent throughout life. Table III shows the deaths from cancer in England and
TABLE III.--Deaths from Tumours in Women other than Lung, Breast and Genital
Organs England and Wales 1958-63
Expected in women
Age Observed in women at male rates F/M ratio
0-15 2,177 . 2,632 083
15-65 55,313 . 100,671 055
65- 102,630 182,229 0*56
0-1 . 207 258 0-80
1-2 161 197 0-82
2-3 . . 196 248 0-79
3-4 . . 206 278 0 74
4-5 . 154 224 0 69
Wales at three age periods, childhood and adolescence, maturity and old age. At
each age there is a significant deficit in women. The difference is apparent in the
youngest age groups; in each of the first five years of life the number of deaths in
girls is less than would have been expected had they been boys. The incidence
oftumours in England and Wales (Doll et al., 1966) shows a similar pattern. There
were 254 cases in girls under the age of 5, 290 would have been expected had they
been boys.
It is undoubtedly true that there are environmental differences in the lives of
men and women and that these may be reflected in the frequency with which
tumours develop. Lung cancer and smoking is the example which perhaps springs
most readily to mind, the occupational bladder cancers (British Medical Journal,
1965) associated with aromatic amines are another. It is also possible that the
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generally greater size of men, and hence the greater number of cells available for
neoplastic change, may be of importance although it is doubtful if this difference
is sufficiently great. The role of sex hormones is uncertain. These compounds
are of importance in some forms of genital and breast cancer and are sometimes
used as therapeutic agents but probably do not play a major role in the therapy
of extra genital tumours.
In young children in particular these differences do not apply. Small boys
and girls are of much the same size, they have similar environments and the part
played in infancy and childhood by the specific steroid sex hormones is small and
yet tumours are less common in girls than boys.
The remaining, and of course the basic factor in which human males and
females differ is in the chromosome constitution. Males have one X chromosome
and one Y chromosome, females have two X chromosomes. I suggest that the
differential between the sexes in this genetic factor is important and that it
constitutes, at least in part, the reason for the difference in tumour incidence
between males and females. The X chromosome, present in the homozygous
state in females and the hemizygous state in males carries many genes not asso-
ciated with sexual development and behaviour. McKusick (1966) lists 119
characters in men which are inherited in the X-linked recessive manner. These
range from " Addison's Disease with Cerebral Sclerosis " to "Zonular Cataract
and Nystagmus " and include Colourblindness, Haemophilia and Muscular Dys-
trophy. The list also includes agammaglobulinaemia, a congenital defect in the
production of one of the types of serum protein which is of importance in the
immune defences of the body. The immunological importance of the X chromo-
some is also shown in the differences in the incidence of some ofthe auto immune
diseases in the two sexes (Burch, 1966). The higher frequency of rheumatoid
arthritis, systemic lupus erythematosus and Hashimoto's disease of the thyroid
are attributed to selective mutations in the two X chromosomes of women com-
pared with the single X chromosome of men.
Little is known of the earliest stages of oncogenesis, the specific alterations in
the phenotype of a cell which free it from control and allow unrestrained multi-
plication. It is known (Nairn, Richmond, McEntegart and Fothergill, 1960)
that there are immunological differences between normal and malignant cells and
it may be inferred from the pronounced lymphocytic infiltration seen in relation
to some tumours, for example seminoma of the testis (Marshall and Dayan, 1964),
that there is an attempt on the part of the host to eliminate tumour cells by a
process analogous to that of graft rejection. The clinically evident cancer, and
indeed even latent cancer only apparent on histological examination, represent
failure on the part of the body to reject abnormal cells as they occur. I believe
it probable that carcinogenesis at the cellular level is a much commoner occurrence
than is the development of overt neoplasms and that usually the neoplastic cells
are destroyed by the bodies' defences. If this is the case the greater immuno-
logical potential ofthe female, contained in her pair of X chromosomes, may allow
ofa better defence mechanism against the " foreign " c3lls ofan incipient neoplasm
and consequently a lower frequency of overt clinical tumours.
This hypothesis is susceptible oftesting both by specially designed experiment
and by suitable observation on the data which are already available on both
human and animal tumours. It is offered as a suggestion which may help in our
understanding and eventual control of malignant disease.
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SUMMARY
Data are presented to show that there is a lower incidence oftumours in women
than in men if lesions of the dissimilar sex organs and of the lung, in which the
influence of cigarette smoking is of major importance, are excluded. Some part
of this difference may be due to environmental factors, to the effect of the differ-
ences in the steroid hormones of the two sexes or to a difference in physical size
and thence of the number of cells available for neoplastic change.
It is suggested in addition that the capacity for immunological control and for
rejection ofincipient cancerous cells is greater in the female than the male and that
this difference also plays a part in the differential incidence oftumours in the two
sexes.
This work was carried out with the aid of a research grant from the Welsh
Hospital Board.
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